Post Graduate Institute of Medical Education and Research (PGIMER)
Post Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh, India5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema | diabetic macular edema | Active, not recruiting | Phase 4 | 2026-08-25 | NCT05224102 | |
| Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis | Digestive System Diseases, pancreas disorder, pancreatitis | Recruiting | Not applicable | 2026-02-09 | NCT07395778 | |
| Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess | Abdominal Abscess, Digestive System Diseases, Infections, Liver Abscess, Suppuration, abscess, liver disorder | Recruiting | Phase 3 | 2025-04-13 | NCT06847126 | |
| Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infections, Inflammation, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Premature Rupture of Fetal Membranes, Preterm Premature Rupture of Fetal Membranes, Sepsis, Systemic Inflammatory Response Syndrome, Urogenital Diseases, neonatal sepsis, pregnancy disorder | Not yet recruiting | Phase 3 | 2024-04-22 | NCT06377397 | |
| Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, neonatal sepsis, toxic shock syndrome | Not yet recruiting | Phase 2 / Phase 3 | 2024-03-12 | NCT06306001 |